Chromatic and Monochromatic Optical Aberrations After Corneal Refractive Surgery

Chromatic and Monochromatic Optical Aberrations After Corneal Refractive Surgery - Preliminary Study Assessing Their Prevalence, Methods of Reductions of Symptoms and Time-dependent Changes in Patients Symptoms

Refractive surgeries can be divided into two distinct categories: 1) corneal surgeries (superficial and deep procedures) carried on the surface of the eye and 2) lens surgeries (phakic IOL, refractive lens exchange) - an intraocular intervention, performed in the anterior or posterior chamber or on the lens. In the proposed protocol focus is on the corneal refractive surgeries impact on monochromatic higher-order aberrations on the one hand and chromatic aberrations on the other. During the surgery in order to get the patient emmetropic, refractive surgery corrects optical defects by decreasing aberrations of lower orders ) simultaneously increases high-order aberrations (that is perceived by the patient as halo, glare or starburst). Informations about prevalence and causes of higher order aberrations after refractive surgery are numerous but there is no information about chromatic aberrations.

Study Overview

Status

Active, not recruiting

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Wrocław, Poland, 50-370
        • Department of Optics and Photonics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients after refractive surgery

Description

Inclusion Criteria:

  • patient after corneal refractive surgery at least for 4 months
  • post surgical refraction within +/- 0.75 diopter of spherical and +/- 1.0 diopter of cylindrical error
  • willing and able to understand and sign an informed consent form.

Exclusion Criteria:

  • patient unable to participate in the study
  • any corneal diseases, eyes trauma or systemic diseases history; keratoconus or tendency of keratoconus
  • corneal macula and obvious pannus; current enrolment in another clinical trial/research project

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Post refractive surgery without HOA
Patients post refractive surgery that do not complain on the high order aberrations such as glare, halo and starburst.
Post refractive surgery with HOA
Patients post refractive surgery that do complain on the high order aberrations such as glare, halo and starburst.
Post refractive surgery with rainbow HOA

Patients post refractive surgery that do complain on:

  1. the high order aberrations such as glare, halo and starburst but with the chromatic aureola
  2. difficulties working with LCD projectors, monitors, cell phones and tablets

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of high order and chromatic aberrations after refractive surgery
Time Frame: 6 months
number of high order and chromatic aberrations after refractive surgery
6 months
Chromoretinoscopy for near (MEM) and distance
Time Frame: 6 months
Conducted with a modified by researchers retinoscopy with distinct filters
6 months
Aberrometry reading for corneal HOA
Time Frame: 6 months
Conducted with aberrometer and corneal tomography
6 months
Transverse chromatic aberration
Time Frame: 6 months
Conducted with a modified by researchers aniseikonia test (with red and green lenses)
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Hue 100 test
Time Frame: 6 months
without and after the introduction of glasses with accommodation support, a blue light filter or concave lenses up to -0,5 diopter
6 months
Change of contrast sensitivity for near vision
Time Frame: 6 months
without and after the introduction of glasses with accommodation support, a blue light filter or concave lenses up to -0,5 diopter
6 months
Visual Function Questionaire 25
Time Frame: 6 months
Conducted with VFQ-25 test
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joanna Przeździecka-Dołyk, PhD, Wrocław University of Science and Technology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2019

Primary Completion (Actual)

February 1, 2022

Study Completion (Anticipated)

February 1, 2024

Study Registration Dates

First Submitted

March 25, 2019

First Submitted That Met QC Criteria

March 26, 2019

First Posted (Actual)

March 28, 2019

Study Record Updates

Last Update Posted (Actual)

March 29, 2022

Last Update Submitted That Met QC Criteria

March 27, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • ST001.2018

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

We intend to share anonymised data

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Refractive Errors

3
Subscribe